Form 4 for ENLT Enlight Renewable Energy Ltd.
Accepted 2026-05-28 17:20:26 ET · period of report 2026-05-27 · accession 0001178913-26-002985 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-28 17:20 | 2026-05-27+ | ENLT | Carr Meron | SVP, STRATEGIC PROJECTS | M - OptEx | $23.22 | +8,500 | 46.9K | +22% | +$197.4K |
| DM | 2026-05-28 17:20 | 2026-05-27+ | ENLT | Carr Meron | SVP, STRATEGIC PROJECTS | F - Tax | $103.65 | -2,097 | 45.8K | -4% | -$217.4K |
| DM | 2026-05-28 17:20 | 2026-05-27+ | ENLT | Carr Meron | SVP, STRATEGIC PROJECTS | S - Sale+OE | $103.65 | -6,403 | 42.5K | -13% | -$663.7K |
| DM | 2026-05-28 17:20 | 2026-05-27+ | ENLT | Carr Meron | SVP, STRATEGIC PROJECTS | M - OptEx | $0.00 | -8,500 | 13.2K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-27 | M | A | 4,075 | $23.22 | 46,540 | D | — | — | (F1) Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F2) Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 2 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-27 | F | D | 1,001 | $103.88 | 45,539 | D | — | — | (F3) These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price. (F4) Represents a transaction price of NIS 296.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction. (F2) Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 3 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-27 | S | D | 3,074 | $103.88 | 42,465 | D | — | — | (F4) Represents a transaction price of NIS 296.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction. (F2) Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 4 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-28 | M | A | 4,425 | $23.22 | 46,890 | D | — | — | (F1) Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F2) Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 5 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-28 | F | D | 1,096 | $103.44 | 45,794 | D | — | — | (F3) These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price. (F5) Represents a transaction price of NIS 293.78, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction. (F2) Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 6 | Common | Ordinary shares, NIS 0.1 par value per share | 2026-05-28 | S | D | 3,329 | $103.44 | 42,465 | D | — | — | (F5) Represents a transaction price of NIS 293.78, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction. (F2) Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| 7 | Derivative | Stock Options (right to buy) | 2026-05-27 | M | D | 4,075 | $0.00 | 17,593 | D | $23.22 · — to 2028-09-30 | 4,075 Ordinary shares, NIS 0.1 par value per share | (F1) Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F6) Stock options were granted on September 30, 2021, with each having vested on September 30, 2025. |
| 8 | Derivative | Stock Options (right to buy) | 2026-05-28 | M | D | 4,425 | $0.00 | 13,168 | D | $23.22 · — to 2028-09-30 | 4,425 Ordinary shares, NIS 0.1 par value per share | (F1) Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. (F6) Stock options were granted on September 30, 2021, with each having vested on September 30, 2025. |